Sitravatinib
Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and Axl.
| Catalog Number | T4349 |
| Alternative Name(s) | MG516 , MGCD516 |
| Research Area | Tyrosine Kinase/Adaptors|||Angiogenesis |
| Molecular Formula | C33H29F2N5O4S |
| CAS# | 1123837-84-2 |
| Purity | 98.90% |
| SMILES | COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Sitravatinib |
| Additional Information | https://www.targetmol.com/datasheet/T4349 |